Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
520.00    6.00 (1.17%)
Bid:
514.00
Ask:
520.00
Spread: 6.00 (1.167%)
Market Cap: £859.64m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Trading Update

31 Jan 2018 07:00

RNS Number : 4053D
Oakley Capital Investments Limited
31 January 2018
 

31 January 2018

 

Oakley Capital Investments Limited

 

Trading update for the twelve months ended 31 December 2017

 

Oakley Capital Investments Limited1 (AIM:OCI, the "Company"), which provides its shareholders with access to a portfolio of high quality companies through its investments in the Oakley Funds2, today announces a trading update for the 12 months ended 31 December 2017.

 

· NAV per share (unaudited) expected to be in the range of £2.43 - £2.45, representing an increase of at least 5% on December 2016 (£2.31)

· The Company has deployed £157.0m in the Oakley Funds and equity co-investments in 2017, during a period of significant investment

· The Company received £88.2m of distributions in the period

· Fund III closed at €800m in September 2017 of which the Company committed €326m

· Interim dividend of 2.25 pence, paid on 26 October 2017

 

Oakley Capital Limited ("Oakley Capital"), the Company's Investment Adviser, estimates that the Company's net asset value ("NAV"), which is subject to the completion of the 31 December 2017 audit of both the Oakley Funds and the Company, will be in the range of £498m to £502m, equating to a NAV per share of £2.43 to £2.45 (31 December 2016: £2.31).

 

Fund III has been active in deploying its capital and has invested €310.2m in five investments during the year, and completed another acquisition in January 2018 investing a further €84.6m. These portfolio companies represent investments in digital consumer, education and technology assets. The average entry EV/EBITDA multiple in Fund III, across all six assets, is currently 9.4x, reflecting the Investment Adviser's continued ability to access quality assets at attractive prices. OCI has an indirect interest in these portfolio companies through its 40.7% holding in Fund III.

 

During the year, the Company received £88.2m of distributions from the Oakley Funds and equity co-investments, relating to exits and refinancings.

 

The Company expects to report its annual results for 2017 on Thursday 15 March 2018.

 

 

- This announcement contains inside information -

 

 

For further information please contact:

 

Oakley Capital Investments Limited

+44 20 7766 6900

Peter Dubens, Director

Steven Tredget, Investor Relations

 

FTI Consulting LLP

+44 20 3727 1000

Edward Bridges / Stephanie Ellis

 

Liberum Capital Limited (Nominated Adviser & Broker)

+44 20 3100 2000

Steve Pearce / Henry Freeman / Jill Li

 

 

1 About Oakley Capital Investments Limited ("OCI")

Oakley Capital Investments Limited is a Bermudian company listed on AIM. OCI seeks to provide investors with long term capital appreciation through its investment in Oakley Capital Private Equity L.P., Oakley Capital Private Equity II, Oakley Capital Private Equity III and through co-investment opportunities.

 

LEI Number: 213800KW6MZUK12CQ815

 

2 About Oakley Capital Private Equity L.P. ("Fund I"), Oakley Capital Private Equity II ("Fund II") and Oakley Capital Private Equity III ("Fund III") collectively the "Oakley Funds"

Oakley Capital Private Equity L.P. and its successor funds, Oakley Capital Private Equity II and Oakley Capital Private Equity III, are unlisted mid-market private equity funds with the aim of providing investors with significant long term capital appreciation. The investment strategy of the funds is to focus on buy-out opportunities in industries with the potential for growth, consolidation and performance improvement.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSDFEESFASEEF
Date   Source Headline
7th Aug 20257:00 amRNSNotice of Annual General Meeting
4th Aug 20257:00 amRNSOakley granted exclusivity to invest in Brevo
1st Aug 20259:06 amRNSConfirmation of Admission to New Listing Category
1st Aug 20257:00 amRNSTotal Voting Rights
30th Jul 20257:03 amRNSTransaction in Own Shares
30th Jul 20257:01 amRNSNew Listing Category
30th Jul 20257:00 amRNSTrading Update for the 6 Months ended 30 June 2025
29th Jul 20257:00 amRNSTransaction in Own Shares
18th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:00 amRNSTransaction in Own Shares
2nd Jul 20257:00 amRNSTotal Voting Rights
1st Jul 20257:00 amRNSOakley expands portfolio of heritage brands
30th Jun 20251:42 pmRNSOakley Capital agrees sale of vLex to Clio
24th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 20257:00 amRNSOakley Capital invests in G3
11th Jun 20257:00 amRNSOakley Capital invests in JBMC
9th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSOakley Capital invests in Infravadis
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20257:00 amRNSTotal Voting Rights
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSTransaction in Own Shares
27th May 20257:00 amRNSTransaction in Own Shares
23rd May 20257:00 amRNSTransaction in Own Shares
22nd May 20257:00 amRNSTransaction in Own Shares
21st May 20257:00 amRNSTransaction in Own Shares
20th May 20257:00 amRNSTransaction in Own Shares
19th May 20257:00 amRNSTransaction in Own Shares
16th May 20257:00 amRNSTransaction in Own Shares
14th May 20257:00 amRNSTransaction in Own Shares
13th May 20257:00 amRNSTransaction in Own Shares
9th May 20257:00 amRNSTransaction in Own Shares
8th May 20257:00 amRNSTransaction in Own Shares
7th May 20257:00 amRNSTransaction in Own Shares
6th May 20257:00 amRNSTransaction in Own Shares
2nd May 20257:00 amRNSTransaction in Own Shares
1st May 20257:00 amRNSTotal Voting Rights
1st May 20257:00 amRNSTransaction in Own Shares
30th Apr 20257:00 amRNSTrading update for the 3 months ended 31 March 25
30th Apr 20257:00 amRNSTransaction in Own Shares
28th Apr 20257:00 amRNSTransaction in Own Shares
25th Apr 20252:02 pmRNSTransaction in Own Shares
23rd Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20257:00 amRNSTransaction in Own Shares
17th Apr 20257:00 amRNSTransaction in Own Shares
16th Apr 20257:00 amRNSTransaction in Own Shares
15th Apr 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.